Trilliant Health builds predictive analytics and data-science products that synthesize first-party and third-party data to provide a comprehensive view of market dynamics and enable intelligent patient acquisition. Its platform helps providers develop strategies to increase market share, predict consumer preferences, and improve patient experience. The company said the new investment will accelerate development of its predictive analytics platform. Trilliant is trusted by more than 75 of the top U.S. health systems representing more than 1,500 hospitals. It recently published the "2021 Trends Shaping the Post-Pandemic Health Economy" report. No revenue or other financial metrics were disclosed in the announcement. Trilliant Health is an analytics and data science company based in Nashville that provides an analytics platform to help healthcare providers execute data‑driven growth strategies. The platform synthesizes all‑payer claims, household, and patient‑generated data from digital marketing campaigns to give a comprehensive view of market dynamics. Trilliant supports use cases including strategy, site selection, M&A, payer negotiations, physician relationship management, marketing, and employer relationship management. Today the company works with over 65 healthcare systems across the nation. Trilliant says it will use the new funding to continue building its data science and technology teams and to enhance its analytics capabilities. The company positions its insights to help providers respond to rising expenses, reimbursement cuts, and growing competition. Trilliant Health offers an analytics platform that uses advanced data science to combine claims data, household data, and user-generated data from digital marketing campaigns. The platform supports healthcare systems on strategy, site selection, M&A, payer negotiations, physician relationship management, marketing, and employer relationship management. The company works with over 60 healthcare systems across the nation to build and execute growth strategies. Led by CEO Hal Andrews, Trilliant plans to use new funding to continue building its data science and technology teams and to enhance its analytics capabilities. Financially, the company completed a $12M Series A round that included more than $7M of new equity capital. The round underscores the company’s focus on expanding product and engineering resources to better serve provider customers. Trilliant Health combines software applications and a data integration platform that links clinical, claims, and patient-generated data to deliver market-focused and patient-level intelligence. The company offers analytics, direct-to-consumer marketing, and physician and patient optimization tools, and has launched an intelligent healthcare CRM platform called Health IDology. Trilliant serves more than 500 hospitals, health systems, and ambulatory surgery centers across the country. It was formed in June 2017 through the merger of Aegis Health and Clariture Health and has since acquired Expression Health Analytics. The company says the additional growth capital will be used to expand product offerings for existing customers, accelerate product development, and pursue new relationships with additional healthcare systems. Trilliant’s stated focus is increasing profitable market share growth for health systems and other healthcare providers.

Total raised

$12M

Funding rounds

4

Latest round

Series A

Latest activity

Aug 2018